Articles tagged with Stem Cell Differentiation
Researchers at UGA created the first blueprint of how stem cells respond to external signaling molecules. The finding reconciles years of conflicting results and enables precise control over stem cell differentiation into specific cell types.
Researchers discovered that high levels of Amd1, an enzyme in the polyamine synthesis pathway, are essential for maintaining embryonic stem cells' (ESCs) self-renewal ability. The study also found that manipulating polyamine levels could help direct ESC differentiation into clinically useful cell types.
Researchers have successfully differentiated human dental pulp stem cells into liver cells using hydrogen sulphide, producing high numbers of pure cells. This breakthrough offers promising results for future liver-cell therapy and transplantation without the risk of teratomas or cancers.
Research reveals LSD1's key function in silencing embryonic stem cell genes during differentiation, allowing cells to adopt new operating systems. The findings hold broader implications for understanding defective operating systems in diseases like cancer.
Researchers in Canada have developed a technique to produce large quantities of endoderm cells from human pluripotent stem cells, overcoming a key hurdle in regenerative medicine. The method allows for significant increases in effective cell production, enabling the potential for regenerative treatments for diabetes and liver disease.
Researchers found that pluripotent stem cells respire at the same level as differentiated body cells but produce very little energy. UCP2 protein blocks respiration substrates from entering mitochondria, allowing glycolysis to dominate. The study suggests that changes in metabolism drive cell differentiation.
Researchers at Mount Sinai School of Medicine discovered fetal stem cells in the placenta can migrate to and repair damaged maternal hearts after a heart attack. The study found that these cells reprogram into beating heart cells, providing a potential therapeutic agent for cardiac regeneration.
Researchers have successfully differentiated mouse ES cells into a tissue resembling the adenohypophysis, the hormone-secreting component of the pituitary gland. The self-organized tissue exhibits functional hormone secretion and can compensate for pituitary function in mice.
Einstein researchers discovered a mechanism governing cell specialization, where a pair of proteins act as super regulators of existing ones. This finding has implications for cancer, stem cell research, and regenerative medicine, as it suggests that specific proteins can be turned on or off to create specialized cells.
Researchers at Inserm have successfully rejuvenated cells from elderly donors, erasing signs of aging and demonstrating the reversibility of cellular aging. The breakthrough uses a new 'cocktail' of six genetic factors to reprogram senescent cells into functional induced pluripotent stem cells.
Researchers from the Chinese University of Hong Kong have developed a technique to reprogram stem cells into a more primitive state, increasing their survival rates and therapeutic efficacy. This breakthrough could lead to improved treatment outcomes for conditions such as degenerative diseases and blood supply disorders.
Researchers successfully used induced pluripotent stem (iPS) cells to treat a mouse model of a rare genetic liver disease. The study demonstrates the potential for iPS cells to be used in human gene therapy to counter pathological effects and promote liver regeneration.
A young scientist has won a $10,000 award for her research on regenerating eyes using stem cells from hair follicles. Her study showed an 80% rate of differentiation in mouse eyes following a cell transplant, highlighting the promising therapeutic potential of these cells.
Researchers at Georgia Tech and Emory University will develop biomaterials to capture molecules from embryonic stem cells for enhanced tissue regeneration in adults. The goal is to harness regenerative power of stem cells without tumor formation or immune system compatibility issues.
Researchers at Tel Aviv University have developed a patented technology that uses bone marrow stem cells to produce neuroprotectors, proteins that shield the brain from neurodegenerative disorders. The treatment has shown efficacy in animal models and is now being tested in human clinical trials.
New research at NIST finds that controlling stem cell shape can induce specific types of cells, offering a simpler and cheaper alternative to biochemical supplements. The study compared five scaffold designs and found that only one, nanofiber scaffolds, successfully directed stem cells into bone-like structures.
Researchers at University of Wisconsin-Madison report 99% protein similarity between two types of do-it-all stem cells, shedding light on their potential applications in cell replacement therapies. The study measured over 6,000 proteins using mass spectrometry and provides insights into their biological role.
The study combines genetic data with mathematical modelling to provide insights into cell differentiation. The findings demonstrate the utility of a systems biology approach, which could have implications for understanding and treating diseases such as cancers caused by abnormal cell function.
Scientists at USC have proven that oncogenes can convert normal cells into stem-like cells, leading to a new approach in treating diseases with stem cell therapy. The study successfully converted human skin cells into brain cells by suppressing p53, suggesting it determines cell fate rather than only cancer outcome.
New research reveals adult stem cells have distinct epigenetic marks that prevent them from differentiating, which are lost over time. This study provides insights into the mechanisms of epigenetics and its role in regulating stem cell behavior, with potential applications in tissue degenerative disorders.
New research controls stem cell development to direct desired cell types, enabling efficient diagnostics and regenerative medicine therapies. The study's findings could be used to develop manufacturing procedures for producing large quantities of stem cells.
A recent study published in Nature has identified a key molecular mechanism that causes stem cells to differentiate into muscle cells in embryos. This breakthrough discovery could lead to new treatments for muscle dysfunction associated with aging and disease.
Researchers from Boston University's Center for Regenerative Medicine have demonstrated that induced pluripotent stem cells (iPSCs) can differentiate into definitive endoderm cells in vitro, with similar functional potential to embryonic stem cells. This finding is significant given the controversy surrounding iPSCs and their potential...
Researchers at Brown University have discovered new molecular interactions in stem cells that control their versatility, using a technology called MEGAShift. The study found that proteins compete and cooperate to produce complex bindings along DNA sequences.
Tuft cells are a rare fifth type of intestinal cell with distinct features and a novel protein signature. They secrete opioids and produce enzymes that synthesize prostaglandins, suggesting potential roles in inflammation and tumorigenesis.
Researchers developed induced conditional self-renewing progenitor cells, which can differentiate into active neurons and other brain cell types. The new stem cell approach shows promising results in an adult rat model of intracerebral hemorrhagic stroke, with no adverse effects observed over five months.
Human amniotic epithelial cells, derived from discarded human placenta, demonstrate therapeutic response when transplanted into lab test tubes and animal models of stroke. The interaction with melatonin receptor MT1 promotes functional recovery.
Researchers at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research found that neural stem cells maintain high levels of reactive oxygen species (ROS) to help regulate normal self-renewal and differentiation. The findings may have significant implications for brain repair and abnormal brain development.
Researchers at University of Illinois found that soft gel substrates promote homogeneous pluripotent stem cell cultures without expensive growth chemicals. This discovery has huge applications in regenerative medicine, offering a step toward understanding the basic biology of stem cells.
Stem cells can sense their environment through touch, with deeper penetration into compliant matrices. The study found that softer surfaces allow cells to feel further, while stiffer surfaces limit their reach.
A research team at Worcester Polytechnic Institute demonstrates the feasibility of delivering adult bone-marrow-derived stem cells using biopolymer microthreads, which support cell growth while maintaining differentiation potential. The technology has the potential to improve cardiac function and treat cardiac arrhythmias.
UC San Diego undergraduate bioengineers develop a new microenvironment that provides all three types of cues necessary for stem cell growth and differentiation. The system uses a gelatin-like hydrogel bathed in an electrolyte solution, mimicking the natural environment to steer stem cells towards specific cell types.
A fully defined culture system has been developed to grow human embryonic stem cells in the lab, reducing guesswork and increasing safety. The system uses a synthetic substrate and defined growth medium, allowing for up to three months of cell culture with minimal batch-to-batch variability.
Researchers found daily whole body vibration improves bone density around the hip joint and femur, reducing a biomarker of bone breakdown. The technique also stimulates stem cells to differentiate into bone cells, potentially aiding fracture healing. Vibration has shown promise in improving glucose uptake and reducing fatty liver disease.
University of Colorado Cancer Center researcher Chuan-Yuan Li and his team have discovered that caspase genes, known as 'grim-reaper' genes, are the gatekeepers that allow differentiated adult cells to regress to undifferentiated stem-like cells. This breakthrough discovery could lead to more efficient use of induced pluripotent stem c...
Researchers have developed a novel strategy for creating patient-specific induced pluripotent stem cells (iPSCs) that exhibits significant advantages over current methods. The new approach uses synthetic modified messenger RNA molecules to reprogram adult cells into iPSCs with high efficiency and safety.
Researchers at Hebrew University develop theoretical model and conduct experiments to understand how stem cells differentiate based on their surroundings' rigidity. The study reveals elongated, muscle-like fibers in cells on rigid supports, differing from brain and bone cell structures on softer or harder substrates.
A research team at the University of Georgia has discovered a critical role for the cancer-causing gene Myc in stem cell biology, which could revolutionize medicine by enabling patient-specific stem cells. The study found that Myc sustains pluripotency by repressing a master regulator gene, and its absence triggers differentiation.
Scientists have devised a method to coax mouse embryonic stem cells into forming highly specific motor neuron subtypes. This achievement may prove useful for future therapies for motor neuron diseases. The study provides new insight into motor neuron differentiation and demonstrates the ability to generate defined motor neuron subtypes.
The University of South Florida researchers warn that the growing number of stem cell journals may compromise the quality of research in the field. They recommend authors to follow Good Publications Practices when choosing a publication outlet.
Researchers mapped epigenetic changes during blood cell differentiation, revealing complex patterns and potential applications for stem cell therapies. The study's findings could guide understanding of diseases like leukemia and lymphoma, paving the way for new treatments.
Stem cell differentiation is a crucial process that can be accelerated using a novel type of matrix, adjusting its stiffness without altering its chemical composition. By analyzing traction forces and cellular behavior, researchers predict stem cell differentiation as early as Day 1.
Researchers discovered a key regulator of spermatogonial stem cell self-renewal by manipulating the STAT3 protein. This process may be linked to degenerative diseases in humans, highlighting the importance of understanding stem-cell activity in disease prevention and treatment.
Researchers at University College London have identified a new mechanism for how polycomb proteins repress the wrong genes in embryonic stem cells. The discovery has significant implications for tissue engineering and cell differentiation, as it reveals how polycomb proteins control gene activity through interaction with short RNAs.
Researchers at Mount Sinai School of Medicine have differentiated human stem cells into heart cells with cardiomyopathy. The study provides a foundation for developing drug therapies to stop or slow the disease.
Researchers at Thomas Jefferson University identified a protein interaction controlling the silencing of Oct4, a key transcription factor necessary for embryonic stem cells to remain pluripotent. The study suggests that attenuated stem cell differentiation contributes to aging by leading to organ or tissue function decline.
Researchers find random gene expression changes during early differentiation, but stability increases by a factor of 100 after nine generations. This discovery sheds light on the mechanisms behind epigenetic inheritance and its impact on stem cell research.
A new study finds that induced pluripotent stem cells differentiate less efficiently and faithfully than embryonic stem cells, which are considered the 'gold standard' for all pluripotent stem cells. Despite their limitations, induced stem cells can still be used for certain applications, such as testing potential new drugs.
Researchers at the Genome Institute of Singapore have identified the genetic molecule Tbx3, which significantly improves the quality of induced pluripotent stem cells (iPS cells). The study successfully produced iPS cells that can recapitulate entire developmental processes and exhibit superior ability for germ-line transmission.
Researchers created a comprehensive map of DNA methylation in human stem cells, identifying previously unknown patterns and associations between methylation and gene expression. The study provides a significant step towards understanding the regulation of cell differentiation and development.
Researchers created a detailed map of the human epigenome during embryonic development, identifying patterns of DNA methylation and its role in regulating gene expression. This breakthrough has significant implications for targeted differentiation of stem cells into specific organs, a crucial consideration for stem cell therapy.
Researchers from Singapore's A*STAR report a novel transcription factor, Nr5a2, can replace classical reprogramming factors to increase iPS cell efficiency. This breakthrough has significant implications for cell-therapy-based medicine and the creation of organs for replacement or transplantation.
Scientists from University of Wisconsin-Madison present a new model of stem cell regulation in Caenorhabditis elegans, balancing stem cell maintenance and differentiation. The regulatory network defines two states - stem cell state and differentiated state - and regulates their balance.
Researchers developed a self-assembling nanofiber scaffold to regulate cell activity, delaying growth and differentiation. The innovation enhances the survival rate of implanted stem cells, allowing them to maintain their youthful state and promote neural circuit regeneration.
Researchers have identified a critical component, Jarid2, of the delicate balancing act between stem cell specialization and cellular chaos. The study reveals how Jarid2 recruits PRC2 to genes important in differentiation and modulates its activity to keep it poised for action.
A new study reveals that three proteins, E2f1, E2f2 and E2f3, play a key role in the transition of stem cells to their final differentiated state. These proteins act as activators in stem cells but switch to repressors when cells begin to differentiate, and can even revert back to activators in cancer cells, promoting tumor growth.
Researchers at the Broad Stem Cell Research Center found that tissue-specific genes are indeed marked by transcription factors, potentially crucial for stem cell function. The study suggests that faithful marking of these genes may be essential for pluripotency and efficient differentiation of stem cells.
Researchers have detected distinct molecular disparities between induced pluripotent stem cells and their parental cells, including differences in epigenetic signatures. These findings provide new insights into the fundamental nature of stem cells and may inform therapeutic applications.
Scientists at Gladstone Institute of Cardiovascular Disease and Stanford University School of Medicine are developing induced pluripotent stem cells to repair damaged heart muscle. The $10 million, 7-year project aims to identify and characterize progenitor cell lines and develop new clinical strategies for regenerative therapies.
Embryonic stem cells exhibit sensitivity to localized cyclic forces due to their softness, affecting gene expression and differentiation. The study suggests that applying controlled mechanical forces could be a new method for directing cell behavior, with implications for therapeutic cloning and regenerative medicine.